Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model

Table 5 Results of the Multivariate Logistic Regression Analysis

Factors	B	S.E	Wald	p	OR	95% CI
WBC	0.136	0.066	4.193	0.041	1.145	1.006–1.304
ALB	− 0.126	0.063	3.995	0.046	0.881	0.779–0.998
The consolidation range exceeding 2/3 of the lung lobes	1.354	0.514	6.947	0.008	3.872	1.415–10.594
Timing of macrolides < 5 days of disease course	− 1.222	0.502	5.927	0.015	0.295	0.110–0.788
Timing of glucocorticoid < 2 weeks of disease course	− 1.734	0.568	9.338	0.002	0.176	0.058–0.537
Treatment timing of fiberoptic bronchoscopy < 2 weeks	− 1.498	0.525	8.147	0.004	0.224	0.080–0.625
Plastic bronchitis	2.444	0.730	11.210	0.001	11.516	2.754–48.152
Constant	4.473	2.499	3.203	0.074	87.604

WBC white blood cell count; ALB albumin; OR odds ratio; CI confidence interval